Biotech Giant Celgene Tops First-Quarter Estimates As Bristol Buyout LoomsInvestors Business Daily • 04/25/19
Top Analyst Reports for Celgene, Schlumberger & Becton, DickinsonZacks Investment Research • 04/24/19
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition ClosesThe Motley Fool • 04/16/19
Celgene (CELG) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 04/09/19
The Refiling Of The NDA For Celgene Is A Major Step Forward Toward 2 Potential ApprovalsSeeking Alpha • 04/02/19